HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Baba, A. Articles by Bero, L. A. Search for Related Content PubMed PubMed Citation Articles by Baba, A. Articles by Bero, L. A. Related Collections Tobacco Control Environmental Tobacco Smoke Health Policy Government

Annamaria Baba, MPH, Daniel M. Cook, PhD, Thomas O. McGarity, JD and Lisa A. Bero, PhD

At the time of writing, Annamaria Baba was with the Department of Clinical Pharmacy at the University of California, San Francisco. Daniel M. Cook is with the Center for Tobacco Control Research and Education at the University of California, San Francisco. Thomas O. McGarity is at the University of Texas School of Law, Austin. Lisa A. Bero is at the Department of Clinical Pharmacy and Institute for Health Policy Studies, University of California, San Francisco.

Correspondence: Request for reprints should be sent to Lisa A. Bero, PhD, Department of Clinical Pharmacy and Health Policy, University of California, San Francisco, 3333 California Street, Suite 420, Box 0613, San Francisco, CA 94143 (e-mail: bero{at}medicine.ucsf.edu).

In the late 1990s, in an effort to dispute the link between secondhand smoke and lung cancer, Philip Morris initiated a campaign to legislate "sound science." The campaign involved enacting data access and data quality laws to obtain previously confidential research data in order to reanalyze it based on industry-generated data quality standards. Philip Morris worked with other corporate interests to form coalitions and workgroups, develop a "data integrity" outreach program, sponsor symposia on "research integrity," and draft language for the new acts.

The tobacco industry played a role in establishing laws that increase corporate influence on public health and regulatory policy decisions.

This article has been cited by other articles:

				L. Claxton A review of conflict of interest, competing interest, and bias for toxicologists Toxicology and Industrial Health, November 1, 2007; 23(10): 557 - 571. [Abstract] [PDF]

				D. E. Apollonio and L. A. Bero The Creation of Industry Front Groups: The Tobacco Industry and "Get Government Off Our Back" Am J Public Health, March 1, 2007; 97(3): 419 - 427. [Abstract] [Full Text] [PDF]

				J. A Francis, A. K Shea, and J. M Samet Challenging the epidemiologic evidence on passive smoking: tactics of tobacco industry expert witnesses Tob. Control, December 1, 2006; 15(suppl_4): iv68 - iv76. [Abstract] [Full Text] [PDF]

				L. Rosenstock Protecting special interests in the name of "good science". JAMA, May 24, 2006; 295(20): 2407 - 2410. [Full Text] [PDF]

				P. A. McDaniel, G. Solomon, and R. E. Malone The Ethics of Industry Experimentation Using Employees: The Case of Taste-Testing Pesticide-Treated Tobacco Am J Public Health, January 1, 2006; 96(1): 37 - 46. [Abstract] [Full Text] [PDF]

				D. Michaels Scientific Evidence and Public Policy Am J Public Health, July 1, 2005; 95(S1): S5 - S7. [Full Text] [PDF]